Lasagas, Clemzy O.

HRN: 27-37-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/01/2025
07/08/2025
ORAL
4.5 Ml
TID
Intestinal Amoebiasis
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines